Brevican (BCAN) (Middle Region) Peptide
BCAN
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits BCAN
- BCAN (Brevican (BCAN))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- PTETLPTPRE RNLASPSPST LVEAREVGEA TGGPELSGVP RGESEETGSS
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-BCAN Antibody(ARP57797_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- BCAN (Brevican (BCAN))
- Synonymes
- fi32a12 Peptide, wu:fi32a12 Peptide, BCAN Peptide, Xbcan Peptide, Cspg7 Peptide, ALPBRE Peptide, BEHAB Peptide, CSPG7 Peptide, brevican Peptide, brevican L homeolog Peptide, bcan Peptide, BCAN Peptide, bcan.L Peptide, Bcan Peptide
- Sujet
-
The function of this protein remains unknown.
Alias Symbols: BEHAB, CSPG7, MGC13038
Protein Interaction Partner: ADAMTS4,FBLN2,MMP1,MMP10,MMP13,MMP2,MMP3,MMP7,MMP8,TNR,FBLN2,MMP1,MMP10,MMP13,MMP2,MMP3,MMP7,MMP8
Protein Size: 671 - Poids moléculaire
- 72 kDa
- ID gène
- 63827
- NCBI Accession
- NM_198427, NP_940819
- UniProt
- Q96GW7
-
Vous êtes ici:
